AtaCor Medical Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 34

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 8

AtaCor Medical General Information

Description

Developer of cardiac pacing and defibrillation leads, and associated delivery tools designed to provide alternatives to traditional devices. The company offers completely extravascular pacing and defibrillation lead systems to reduce procedural complications and improve patient safety, enabling healthcare providers to offer more versatile and less invasive options for their patients.

Contact Information

Website
www.atacor.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 905 Calle Amanecer
  • Suite 360
  • San Clemente, CA 92673
  • United States
+1 (949)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 905 Calle Amanecer
  • Suite 360
  • San Clemente, CA 92673
  • United States
+1 (949)

AtaCor Medical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AtaCor Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private Completed Product Development
7. Later Stage VC 06-Oct-2025 Completed Product Development
6. Later Stage VC (Series C) 24-Apr-2024 Completed Startup
5. Later Stage VC (Series B1) 06-Apr-2022 Completed Startup
4. Later Stage VC (Series B) 28-Apr-2020 Completed Startup
3. Accelerator/Incubator 08-Nov-2018 Completed Startup
2. Early Stage VC (Series A) 18-Sep-2018 $8.8M $8.8M Completed Startup
1. Accelerator/Incubator 12-Jun-2018 Completed Startup
To view AtaCor Medical’s complete valuation and funding history, request access »

AtaCor Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C-2
Series C-1
Series B1
Series B-V 24,702,775 $0.000100 8% $0.65 $0.65 1x $0.43 14.82%
Series A 14,607,308 $0.000100 8% $0.65 $0.65 1x $0.43 8.76%
To view AtaCor Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AtaCor Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cardiac pacing and defibrillation leads, and associated delivery tools designed to provide alternatives to
Therapeutic Devices
San Clemente, CA
34 As of 2026

South Jordan, UT
 

Vapi, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AtaCor Medical Competitors (35)

One of AtaCor Medical’s 35 competitors is BioTrace Medical, a Formerly VC-backed company based in South Jordan, UT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioTrace Medical Formerly VC-backed South Jordan, UT
Meril Life Sciences Private Equity-Backed Vapi, India
Fisher Wallace Labs Venture Capital-Backed New York, NY
Abiomed Corporate Backed or Acquired Danvers, MA
CardioRenal Systems Venture Capital-Backed Milford, MA
You’re viewing 5 of 35 competitors. Get the full list »

AtaCor Medical Patents

AtaCor Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240164810-A1 Systems and methods for lead anchor insertion Pending 23-Nov-2022
US-20240042197-A1 Implantable electrical leads and associated delivery and control systems Pending 04-Aug-2022
US-20240042196-A1 Systems and methods for lead fixation Inactive 04-Aug-2022
CA-3240237-A1 Implantable electrical leads and associated delivery and control systems Pending 24-Nov-2021
EP-4436497-A1 Implantable electrical leads and associated delivery and control systems Pending 24-Nov-2021 A61B17/0057
To view AtaCor Medical’s complete patent history, request access »

AtaCor Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AtaCor Medical Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arboretum Ventures Venture Capital Minority
Longview Healthcare Ventures Venture Capital Minority
BayMed Venture Partners Venture Capital Minority
Catalyst Health Ventures Venture Capital Minority
Hatteras Venture Partners Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

AtaCor Medical FAQs

  • When was AtaCor Medical founded?

    AtaCor Medical was founded in 2014.

  • Where is AtaCor Medical headquartered?

    AtaCor Medical is headquartered in San Clemente, CA.

  • What is the size of AtaCor Medical?

    AtaCor Medical has 34 total employees.

  • What industry is AtaCor Medical in?

    AtaCor Medical’s primary industry is Therapeutic Devices.

  • Is AtaCor Medical a private or public company?

    AtaCor Medical is a Private company.

  • What is AtaCor Medical’s current revenue?

    The current revenue for AtaCor Medical is .

  • How much funding has AtaCor Medical raised over time?

    AtaCor Medical has raised $149M.

  • Who are AtaCor Medical’s investors?

    Arboretum Ventures, Longview Healthcare Ventures, BayMed Venture Partners, Catalyst Health Ventures, and Hatteras Venture Partners are 5 of 8 investors who have invested in AtaCor Medical.

  • Who are AtaCor Medical’s competitors?

    BioTrace Medical, Meril Life Sciences, Fisher Wallace Labs, Abiomed, and CardioRenal Systems are some of the 35 competitors of AtaCor Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process